As seen in Table 2, 13 of the 52 (25%) patients had an identifiable cause: 3 were associated ACE inhibitor use, 3 with malignancy, 5 with autoimmune disease, 2 with NSAID use, and no patients with low C1-INH and C4 levels. The gene discussed is ACE; the disease is autoimmune disease.